FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4521611000001101: Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26584901000001111 Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41474701000001114 Celance 250microgram tablets (Eli Lilly and Company Ltd) 57 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Is a Pergolide 250microgram tablets 57 tablet true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Is pack of Celance 250microgram tablets (Eli Lilly & Co Ltd) false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has active ingredient Pergolide mesilate false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has active ingredient Pergolide false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has AMP Celance 250microgram tablets (Eli Lilly & Co Ltd) true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has specific active ingredient Pergolide mesilate true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Celance 250microgram tablets (Eli Lilly & Co Ltd) 57 tablet Has basis of strength substance Pergolide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start